Company to host webcast Monday, December 15, 2025 at 8:30 a.m. ETBOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and ...

Proceeds to further advance clinical development of BH-30643, a first-in-class, macrocyclic, CNS-active, mutant-selective OMNI-EGFRTM inhibitor ...

Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer ...

Now iconic, Staffordshire dogs are emblems of Victorian kitsch.

Phare Bio, a biotech social venture harnessing artificial intelligence to accelerate antibiotic discovery and development, and Basilea Pharmaceutica, a commercial-stage biopharmaceutical company ...

The Springboks have done it again - successfully defending their Rugby Championship title against the All Blacks, the Wallabies, and Los Pumas. The Springboks continue to make the nation proud, as ...

If a merger is approved, Willamette University and Pacific University would become the University of the Northwest ...

Lyon, France and Liège, Belgium – – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced the ...

We analysed reviews of the biggest mirrorless camera releases of 2025 to produce a Metascore ranking based on specs, ...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

Chaired by globally renowned nuclear medicine expert Prof. Ken Herrmann, M.D. Other Board members James Cook, Jason Lewis, Ph.D., and Michael ...